Patrick I. Borgen, MD

Patrick I. Borgen, MD, discusses the need for improved risk stratification in early-stage breast cancer.

Patrick Borgen, MD, discusses how advances in artificial intelligence may influence the future of oncology practice.

Patrick I. Borgen, MD, discusses research outlining the current clinical applications and limitations of artificial intelligence in oncology practice.

Patrick Borgen, MD, discusses the evolution of immuno-oncology clinical trials in breast cancer.

Patrick Borgen, MD, discusses common symptoms of breast cancer in male patients.

Patrick Borgen, MD, discusses the prognosis of breast cancer in male patients.

Patrick I. Borgen, MD, discusses eliminating the use of opioids in patients with breast cancer.

History will report that the COVID-19 pandemic in Brooklyn, New York peaked on or about April 12, 2020; however, due to the protracted hospitalization experienced by severe COVID-19–positive patients, the heavy in-patient burden continues today.

Global COVID-19 cases exceed 1.7 million confirmed cases, and a staggering daily growth rate.

The SARS COVID-19 virus pandemic came out of nowhere, circling the globe with shocking speed and with a vengeance.

Patrick I. Borgen, MD, discusses what is currently known about coronavirus 2019 and unanswered questions that still need to be addressed.

Patrick I. Borgen, MD, discusses the trend toward surgical de-escalation in patients with breast cancer.

Patrick I. Borgen, MD, chair, Department of Surgery, director, Breast Cancer, Maimonides Medical Center, discusses the opioid crisis related to the treatment of patients with breast cancer.

As evidence grows that opioids may potentially worsen oncologic outcomes, surgeons and oncology providers must take an active role in addressing the opioid crisis by adopting similar protocols that decrease the quantity of narcotics available for diversion while ensuring safe patient care.

Patrick I. Borgen, MD, chair, Department of Surgery, director, Breast Cancer, Maimonides Medical Center, discusses the potential global impact of biosimilars in oncology.

Patrick I. Borgen, MD, chair, Department of Surgery, director, Breast Cancer, Maimonides Medical Center, discusses the equivalence of biosimilars in oncology.

Patrick I. Borgen, MD, chairman of surgery, director of the Breast Cancer Program, Maimonides Medical Center, discusses axillary node dissection in patients with early-stage breast cancer.

Patrick I. Borgen, MD, chairman of surgery, director of the Breast Cancer Program, Maimonides Medical Center, and chair of the Miami Breast Cancer Conference, discusses the evolution of breast cancer treatment in recent years. Borgen shared his insight in an interview during the meeting.

Patrick I. Borgen, MD, chair, Department of Surgery, head, Brooklyn Cancer Center, Maimonides Medical Center, compares the efficacy of surgical versus medical treatment of patients with breast cancer.